Anticonvulsant activity of Pseudospondias microcarpa (A. Rich) Engl. hydroethanolic leaf extract in mice: The role of excitatory/inhibitory neurotransmission and nitric oxide pathway

Adongo, 2014, Effects of hyrdroethanolic leaf extract of Pseudospondias microcarpa (A. rich.) Engl. (Anacardiaceae) on the central nervous system in mice, J. Phytopharm., 3, 410, 10.31254/phyto.2014.3607 Ahmed, 2005, Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment, Neurochem. Int., 47, 248, 10.1016/j.neuint.2005.04.025 Akula, 2008, Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice, Eur. J. Pharmacol., 587, 129, 10.1016/j.ejphar.2008.03.038 Bahremand, 2010, Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice, Epilepsy Res., 89, 295, 10.1016/j.eplepsyres.2010.02.001 Barton, 2001, Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy, Epilepsy Res., 47, 217, 10.1016/S0920-1211(01)00302-3 Bhutada, 2010, Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice, Epilepsy Behav., 18, 207, 10.1016/j.yebeh.2010.03.007 Brito, 2009, Diphenyl diselenide and diphenyl ditelluride increase the latency for 4-aminopyridine-induced chemical seizure and prevent death in mice, Acta Biochim Pol., 56, 125, 10.18388/abp.2009_2524 Brodie, 2005, Diagnosing and predicting refractory epilepsy, Acta Neurol. Scand., 112, 36, 10.1111/j.1600-0404.2005.00507.x Brogden, 1991, Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist, Drugs, 42, 1061, 10.2165/00003495-199142060-00010 Brown, 1953, Comparative assay of antiepileptic drugs by "psychomotor" seizure test and minimal electroshock threshold test, J. Pharmacol. Exp. Ther., 107, 273 Browne, 2001, Epilepsy, New Engl. J. Med., 344, 1145, 10.1056/NEJM200104123441507 Burkill, H.M., 1985. The useful plants of west tropical Africa. Edition 2. Vol. 1: families AD. Kew, Royal Botanic Gardens. Castel-Branco, 2009, The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs, Methods Find. Exp. Clin. Pharmacol., 31, 101, 10.1358/mf.2009.31.2.1338414 Costa, 1975, Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum, Adv. Biochem. Psychopharmacol., 14, 113 Curtis, 1971, The specificity of strychnine as a glycine antagonist in the mammalian spinal cord, Exp. Brain Res., 12, 547, 10.1007/BF00234248 de Boer, 2008, The global burden and stigma of epilepsy, Epilepsy Behav., 12, 540, 10.1016/j.yebeh.2007.12.019 Duncan, 2005, The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6Hz psychomotor seizure model, Epilepsy Res., 67, 81, 10.1016/j.eplepsyres.2005.08.009 File, 1986, Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788, Psychopharmacol. (Berl.), 88, 1, 10.1007/BF00310505 Fragoso-Veloz, 1992, NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine, Eur. J. Pharmacol., 221, 275, 10.1016/0014-2999(92)90713-E Ghasemi, 2010, Inhibition of NMDA receptor/NO signaling blocked tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice, Epilepsy Res., 91, 39, 10.1016/j.eplepsyres.2010.06.010 Gholipour, 2008, Role of nitric oxide in the anticonvulsive effect of progesterone, Epilepsy Behav., 13, 579, 10.1016/j.yebeh.2008.07.011 Gholipour, 2009, The interaction of sildenafil with the anticonvulsant effect of diazepam, Eur. J. Pharmacol., 617, 79, 10.1016/j.ejphar.2009.06.061 Giardina, 2001 Hecht, 2012, Retigabine. A novel anticonvulsant drug for the adjunctive treatment of partial seizures, Med. Mon. für Pharm., 35, 166 Herrero, 2002, Two new actions of topiramate: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance, Neuropharmacology, 42, 210, 10.1016/S0028-3908(01)00171-X Holmes, 2007, Animal model studies application to human patients, Neurology, 69, S28, 10.1212/01.wnl.0000302369.24230.c6 Jackson, 1999, Effects of sildenafil citrate on human hemodynamics, Am. J. Cardiol., 83, 13c, 10.1016/S0002-9149(99)00043-0 Kaputlu, 1997, l-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice, Brain Res., 753, 98, 10.1016/S0006-8993(96)01496-5 Kasture, 2002, Anticonvulsive activity of Butea monosperma flowers in laboratory animals, Pharmacol. Biochem. Behav., 72, 965, 10.1016/S0091-3057(02)00815-8 Kisangau, 2008, In vitro antimicrobial assay of plants used in traditional medicine in Bukoba rural district, Tanzania, Afr. J. Tradit., Complement. Altern. Med., 4, 510, 10.4314/ajtcam.v4i4.31245 Kubova, 2009, MODELS | Pharmacology of seizure drugs, 780 Leewanich, 1996, Behavioral studies on alkaloids extracted from the leaves of Hunteria zeylanica, Biol. Pharm. Bull., 19, 394, 10.1248/bpb.19.394 Löscher, 1998, New visions in the pharmacology of anticonvulsion, Eur. J. Pharmacol., 342, 1, 10.1016/S0014-2999(97)01514-8 Löscher, 2002, Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy, Epilepsy Res., 50, 105, 10.1016/S0920-1211(02)00073-6 Löscher, 2002, Current status and future directions in the pharmacotherapy of epilepsy, Trends Pharmacol. Sci., 23, 113, 10.1016/S0165-6147(00)01974-X Löscher, 2011, Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs, Seizure, 20, 359, 10.1016/j.seizure.2011.01.003 Luszczki, 2012, Isobolographic characterization of interaction of levetiracetam with clobazam in the mouse 6 Hz psychomotor seizure model, J. Pre-Clin. Clin. Res., 6, 25 Łuszczki, 2008, Characterization of acute adverse-effect profile of carbamazepine and valproate in the grip-strength test in mice, J. Pre-Clin. Clin. Res., 2, 46 Macdonald, 1995, Antiepileptic drug mechanisms of action, Epilepsia, 36, S2, 10.1111/j.1528-1157.1995.tb05996.x Malebo, 2009, Antiplasmodial, anti-trypanosomal, anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal plants, Tanzan. J. Health Res., 11, 10.4314/thrb.v11i4.50194 Meller, 1993, Nitric oxide (NO) and nociceptive processing in the spinal cord, Pain, 52, 127, 10.1016/0304-3959(93)90124-8 Meyer, 1979, A method for the routine assessment of fore- and hindlimb grip strength of rats and mice, Neurobehav. Toxicol., 1, 233 Molgo, 1985, [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates], J. De. Pharmacol., 16, 109 Morales-Villagrán, 1996, Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine, Eur. J. Pharmacol., 305, 87, 10.1016/0014-2999(96)00157-4 Nassiri-Asl, 2007, Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors, BMC Complement Altern. Med, 7, 26, 10.1186/1472-6882-7-26 Nicoll, 2001, Introduction to the pharmacology of CNS drugs, 351 Noh, 2006, Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice, Brain Res., 1075, 193, 10.1016/j.brainres.2005.12.017 NRC, 2010 Oliveira, 2001, Anticonvulsant properties of N-salicyloyltryptamine in mice, Pharmacol. Biochem. Behav., 68, 199, 10.1016/S0091-3057(00)00484-6 Osonoe, 1994, Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats, Brain Res., 663, 338, 10.1016/0006-8993(94)91283-1 Patil, 2011, Anticonvulsant activity of aqueous root extract of Ficus religiosa, J. Ethnopharmacol., 133, 92, 10.1016/j.jep.2010.09.004 Paul, 2003, The effect of N-nitro-L-arginine methyl ester posttreatment on the anticonvulsant effect of phenobarbitone and diazepam on picrotoxin-induced convulsions in rats, Pharmacol. Biochem. Behav., 74, 789, 10.1016/S0091-3057(03)00028-5 Paul, 2002, Evidence for an involvement of nitric oxide and gamma aminobutyric acid in the anticonvulsant action of l-arginine on picrotoxin-induced convulsions in rats, Pharmacol. Biochem. Behav., 72, 515, 10.1016/S0091-3057(02)00713-X Pongs, 1999, Voltage-gated potassium channels: from hyperexcitability to excitement, FEBS Lett., 452, 31, 10.1016/S0014-5793(99)00535-9 Porter, 1984, Antiepileptic Drug Development Program, Cleve Clin. Q., 51, 293, 10.3949/ccjm.51.2.293 Porter, 1992, New antiepileptic drugs: from serendipity to rational discovery, Epilepsia, 33, S1, 10.1111/j.1528-1157.1992.tb05895.x Quintans-Junior, 2008, Phythochemical screening and anticonvulsant activity of Cymbopogon winterianus Jowitt (Poaceae) leaf essential oil in rodents, Phytomedicine, 15, 619, 10.1016/j.phymed.2007.09.018 Raol, 2012, Chapter 1 - Experimental models of seizures and epilepsies, 57, 10.1016/B978-0-12-394596-9.00003-2 Raygude, 2012, Anticonvulsant effect of fisetin by modulation of endogenous biomarkers, Biomed. Prev. Nutr., 2, 215, 10.1016/j.bionut.2012.04.005 Rees, 1990, Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br. J. Pharmacol., 101, 746, 10.1111/j.1476-5381.1990.tb14151.x Riazi, 2006, The proconvulsant effect of sildenafil in mice: role of nitric oxide–cGMP pathway, Br. J. Pharmacol., 147, 935, 10.1038/sj.bjp.0706680 Rogawski, 1990, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev., 42, 223 Rostock, 1996, D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures, Epilepsy Res., 23, 211, 10.1016/0920-1211(95)00101-8 Royes, 2007, The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: an electroencephalographic and neurochemical study, Epilepsy Res., 73, 228, 10.1016/j.eplepsyres.2006.10.009 Rundfeldt, 1997, The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells, Eur. J. Pharmacol., 336, 243, 10.1016/S0014-2999(97)01249-1 Snyder, 1991, Nitric oxide as a neuronal messenger, Trends Pharmacol. Sci., 12, 125, 10.1016/0165-6147(91)90526-X Surges, 2008, Review: is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited, Ther. Adv. Neurol. Disord., 1, 13, 10.1177/1756285608094212 Talarek, 2003, Role of nitric oxide in anticonvulsant effects of benzodiazepines in mice, Pol. J. Pharmacol., 55, 181 Tapia, 1999, Review article On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo, Neurochem. Int., 34, 23, 10.1016/S0197-0186(98)00061-8 Velíšek, 2006, Chapter 11 - Models of Chemically-Induced Acute Seizures, 127 Vergnes, 2000, Selective susceptibility to inhibitors of GABA synthesis and antagonists of GABAA receptor in rats with genetic absence epilepsy, Exp. Neurol., 161, 714, 10.1006/exnr.1999.7302 Yondo, J., Fomekong, G.I.D., Kontangui, M.-.C., Wabo, J.P., Tankoua, O.F., Kulate, J.-.R., Mpoame, B.M., 2009. In vitro antioxidant potential and phytochemical constituents of three cameroonian medicinal plants used to manage parasitic diseases, Annals of Nutrition and Metabolism. Karger Allschwilerstrasse 10, ch-4009 Basel, Switzerland, pp. 205–205. Zadrozniak, 2009, Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice, Pharmacol. Rep., 61, 737, 10.1016/S1734-1140(09)70128-8 Zarri, 1994, Modulation by nitric oxide of rat brain GABAA receptors, Neurosci. Lett., 180, 239, 10.1016/0304-3940(94)90529-0